Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Hsu

Showing results (101-110 of 288) with videos related to

Pageof 29
Sort By:
Biometrical Journal. Biometrische Zeitschrift|April 5, 2013
Panel forum on multiple comparison procedures: a commentary from a complex trial design and analysis planSue-Jane Wang, Frank Bretz, Alex Dmitrienko, et al.
Ophthalmology|October 23, 2013
The role of topical antibiotic prophylaxis to prevent endophthalmitis after intravitreal injectionPhilip Storey, Michael Dollin, John Pitcher, et al.
Retina (Philadelphia, Pa.)|May 29, 2026
Factors associated with persistent vision loss in eyes with diabetic macular edema and non-proliferative diabetic retinopathy after lost-to-follow-upSidra Zafar, Bita Momenaei, Irene Kim, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 6, 2004
Extract of Reishi polysaccharides induces cytokine expression via TLR4-modulated protein kinase signaling pathwaysHsien-Yeh Hsu, Kuo-Feng Hua, Chun-Cheng Lin, et al.
JAMA Ophthalmology|February 26, 2016
Topical Dorzolamide-Timolol With Intravitreous Anti-Vascular Endothelial Growth Factor for Neovascular Age-Related Macular DegenerationJayanth Sridhar, Jason Hsu, Abtin Shahlaee, et al.
Retina (Philadelphia, Pa.)|July 23, 2015
MICROBIAL SPECTRUM AND OUTCOMES OF ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION VERSUS PARS PLANA VITRECTOMYSunir J Garg, Michael Dollin, Philip Storey, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|July 26, 2021
Systemic Immunosuppression and Risk of Endophthalmitis After Intravitreal Anti-Vascular Endothelial Growth Factor InjectionsSamir N Patel, Philip P Storey, Julie S Kim, et al.
Retinal Cases & Brief Reports|June 5, 2018
TOPICAL DORZOLAMIDE-TIMOLOL WITH INTRAVITREOUS ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR RETINAL VEIN OCCLUSION: A PILOT STUDYAnthony Obeid, Jason Hsu, David Ehmann, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|April 19, 2019
Intravitreal Anti-Vascular Endothelial Growth Factor Injections for Macular Edema Associated With Central Retinal Vein Occlusion in Patients Age 40 Years or YoungerXinxiao Gao, Anthony Obeid, Christopher M Aderman, et al.
Frontiers in Immunology|July 13, 2023
Circulating Reelin promotes inflammation and modulates disease activity in acute and long COVID-19 casesLaurent Calvier, Aleksandra Drelich, Jason Hsu, et al.
Pageof 29

Showing results (101-110 of 288) with videos related to

Sort By:
Pageof 29
Biometrical Journal. Biometrische Zeitschrift|April 5, 2013
Panel forum on multiple comparison procedures: a commentary from a complex trial design and analysis planSue-Jane Wang, Frank Bretz, Alex Dmitrienko, et al.
Ophthalmology|October 23, 2013
The role of topical antibiotic prophylaxis to prevent endophthalmitis after intravitreal injectionPhilip Storey, Michael Dollin, John Pitcher, et al.
Retina (Philadelphia, Pa.)|May 29, 2026
Factors associated with persistent vision loss in eyes with diabetic macular edema and non-proliferative diabetic retinopathy after lost-to-follow-upSidra Zafar, Bita Momenaei, Irene Kim, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 6, 2004
Extract of Reishi polysaccharides induces cytokine expression via TLR4-modulated protein kinase signaling pathwaysHsien-Yeh Hsu, Kuo-Feng Hua, Chun-Cheng Lin, et al.
JAMA Ophthalmology|February 26, 2016
Topical Dorzolamide-Timolol With Intravitreous Anti-Vascular Endothelial Growth Factor for Neovascular Age-Related Macular DegenerationJayanth Sridhar, Jason Hsu, Abtin Shahlaee, et al.
Retina (Philadelphia, Pa.)|July 23, 2015
MICROBIAL SPECTRUM AND OUTCOMES OF ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION VERSUS PARS PLANA VITRECTOMYSunir J Garg, Michael Dollin, Philip Storey, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|July 26, 2021
Systemic Immunosuppression and Risk of Endophthalmitis After Intravitreal Anti-Vascular Endothelial Growth Factor InjectionsSamir N Patel, Philip P Storey, Julie S Kim, et al.
Retinal Cases & Brief Reports|June 5, 2018
TOPICAL DORZOLAMIDE-TIMOLOL WITH INTRAVITREOUS ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR RETINAL VEIN OCCLUSION: A PILOT STUDYAnthony Obeid, Jason Hsu, David Ehmann, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|April 19, 2019
Intravitreal Anti-Vascular Endothelial Growth Factor Injections for Macular Edema Associated With Central Retinal Vein Occlusion in Patients Age 40 Years or YoungerXinxiao Gao, Anthony Obeid, Christopher M Aderman, et al.
Frontiers in Immunology|July 13, 2023
Circulating Reelin promotes inflammation and modulates disease activity in acute and long COVID-19 casesLaurent Calvier, Aleksandra Drelich, Jason Hsu, et al.
Pageof 29